The ADNI Administrative Core: Ensuring ADNI's success and informing future AD clinical trials is a research paper published in Alzheimer s & Dementia (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIA NIH HHS
Grant: R33 AG062867
NIA NIH HHS
Grant: U19 AG024904
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 3U19AG024904-18S3
Alzheimer's Disease Neuroimaging Initiative (ADNI4)
Alzheimer's Drug Discovery Foundation
Alzheimer's Association
Elan Pharmaceuticals, Inc.
Fujirebio
GE Healthcare
Northern California Institute for Research and Education
Transition Therapeutics
Alzheimer's Association
Eli Lilly and Company
Merck
NIBIB NIH HHS
National Institute on Aging
Neurotrack Technologies
Pfizer Inc.
Takeda Pharmaceutical Company
Araclon Biotech
CereSpir, Inc.
Johnson & Johnson Pharmaceutical Research & Development LLC
Novartis Pharmaceuticals Corporation
AbbVie
Bristol-Myers Squibb Company
IXICO Ltd.
Lumosity; Lundbeck
National Institute of Biomedical Imaging and Bioengineering
EuroImmun
Janssen Alzheimer Immunotherapy Research & Development, LLC
Merck & Co., Inc.
NIA
NeuroRx Research
Piramal Imaging; Servier
BioClinica, Inc.
Biogen
CIHR
Meso Scale Diagnostics, LLC
Canadian Institutes of Health Research
Fujirebio Europe
Pfizer
Alzheimer's Drug Discovery Foundation
BioClinica
Cogstate; Eisai Inc.
Janssen Alzheimer Immunotherapy Research & Development, LLC
Alzheimer's Drug Discovery Foundation
Bristol-Myers Squibb Company
Takeda Pharmaceutical Company
Alzheimer's Association
Araclon Biotech
Merck & Co., Inc.
Eli Lilly and Company
NIA
EuroImmun
Biogen
Meso Scale Diagnostics, LLC
Novartis Pharmaceuticals Corporation
CereSpir, Inc.
Northern California Institute for Research and Education
BioClinica, Inc.
GE Healthcare
Johnson & Johnson Pharmaceutical Research & Development LLC
AbbVie
Lumosity; Lundbeck
Transition Therapeutics
Cogstate; Eisai Inc.
NIBIB NIH HHS
Piramal Imaging; Servier
Pfizer Inc.
CIHR
Elan Pharmaceuticals, Inc.
IXICO Ltd.
NeuroRx Research
Fujirebio
Neurotrack Technologies
FWCI
1.71
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals